Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Biomerica Inc. BMRA

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Recent & Breaking News (NDAQ:BMRA)

Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19

GlobeNewswire June 16, 2020

Mayo Clinic joins Biomerica's InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial

GlobeNewswire June 1, 2020

Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution

GlobeNewswire May 7, 2020

Biomerica Announces Third Quarter Financial Results

GlobeNewswire April 15, 2020

Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs

GlobeNewswire April 2, 2020

Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure

GlobeNewswire March 17, 2020

Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund

GlobeNewswire February 26, 2020

Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter

GlobeNewswire January 15, 2020

Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica's InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial

GlobeNewswire January 7, 2020

Biomerica Reports 1st Quarter Fiscal 2020 Financials

GlobeNewswire October 16, 2019

Biomerica Announces Fiscal Year End 2019 Financial Results

GlobeNewswire August 30, 2019

Republic of Colombia's food and drug regulatory agency grants clearance for Biomerica's colorectal cancer screening test to be sold in Colombia

GlobeNewswire August 21, 2019

Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.

GlobeNewswire June 5, 2019

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)

GlobeNewswire April 8, 2019

LD Micro Virtual Conference Is Live, March 12th and 13th

Accesswire March 12, 2019

Biomerica Announces Updates for H. Pylori Clinical Studies

GlobeNewswire February 5, 2019

Biomerica Announces Second Quarter Financial Results

GlobeNewswire January 15, 2019

Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer

GlobeNewswire November 28, 2018

Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications

GlobeNewswire November 16, 2018

Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud

GlobeNewswire November 7, 2018